As medical devices become increasingly connected, the risks - and regulatory expectations - around cybersecurity grow. This joint presentation by Naomi Schwartz (VP of Regulatory Strategy, Medcrypt) and Dr. Omar Al-Kalaa (Founder, Inovectrum) breaks down the layered complexity of wireless connectivity in medical devices, the evolving FDA regulatory landscape, and how connectivity can be a security enabler rather than a liability.
From premarket expectations to postmarket patching strategies, this session outlines what manufacturers need to know - and do - to stay compliant, secure, and competitive in today’s digital health ecosystem.
Our team of FDA analysts and cybersecurity experts provide robust and actionable cybersecurity roadmaps to ensure you meet FDA requirements. Get the Medcrypt advantage today!
.svg)